Gold prices just lower; monthly gains on track
Investing.com - BTIG maintained its Neutral rating on Cerus (NASDAQ:CERS) following the company’s second-quarter financial results that exceeded expectations. According to InvestingPro data, Cerus achieved 13.25% revenue growth over the last twelve months, with a healthy gross margin of 56.09%.
The research firm noted that Cerus delivered stronger-than-anticipated performance in the quarter, driven by growth in its platelets business and better-than-expected results from its newer IFC product line.
BTIG highlighted that Cerus is experiencing early success with its CE-Marked, next-generation INT 200 Illuminator, with the launch tracking ahead of company expectations.
The firm also pointed to the ongoing European review of Cerus’ CE mark for INTERCEPT RBCs, which BTIG estimates will require approximately another year to complete, potentially serving as an important catalyst for the stock.
BTIG observed that Cerus shares currently trade at approximately 1x its 2026 revenue estimate, below the small-cap peer average of about 1.6x, but maintained its Neutral stance as it believes the stock is "roughly fairly valued." InvestingPro analysis suggests the stock is currently undervalued, trading near its 52-week low of $1.12. Get detailed valuation metrics and 6 additional ProTips with an InvestingPro subscription.
In other recent news, Cerus Corporation reported its second-quarter 2025 earnings, showcasing a revenue of $60.1 million, which surpassed the analyst forecast of $54.37 million. The company also met earnings per share expectations at -$0.03. Product revenue specifically reached $52.4 million, exceeding both Cantor Fitzgerald’s estimate of $49.5 million and the FactSet consensus of $48.0 million, marking a year-over-year growth of approximately 16%. This growth was primarily driven by increased sales in Intercept Fibrinogen Complex and global platelet products. In light of these results, Cantor Fitzgerald maintained its Overweight rating and a price target of $4.00 on Cerus. These developments highlight the company’s strong performance in the latest quarter.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.